RELOVAIR® Lung Deflation Study
NCT01691885
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Fluticasone Furoate
DRUG:
Vilanterol
Sponsor
GlaxoSmithKline